Human papillomavirus infection and the development of cervical cancer and related genital neoplasias

International Journal of Infectious Diseases

Volumn 11, Issue SUPPL. 2, 2007, Pages

  Paavonen, Jorma ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; Genital warts; Human papillomavirus; Pathophysiology; Prevalence; Screening

Indexed keywords

DOUBLE STRANDED DNA; QUADRIVALENT WART VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; WART VIRUS VACCINE;

CANCER GRADING; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CARBON DIOXIDE LASER; CARCINOMA IN SITU; CONDYLOMA; DEVELOPING COUNTRY; DNA STRAND; FEMALE; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; LARGE LOOP EXCISION OF TRANSFORMATION ZONE; LOOP ELECTROSURGICAL EXCISION PROCEDURE; PAPANICOLAOU TEST; PREGNANCY OUTCOME; REVIEW; RISK ASSESSMENT; SURGICAL RISK; SURGICAL TECHNIQUE; UTERINE CERVIX CANCER; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS CARCINOGENESIS; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION; WART VIRUS;

FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 37349078725     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(07)60015-0     Document Type: Review

References (65)

1. Department of Health and Human Services Centers for Disease Control and Prevention. Genital HPV Infection Fact Sheet (web site) (2004). http://www.cdc.gov/std/hpv/stdfact-hpv.htm accessed 2/26/06.
2. World Health Organization. Initiative for vaccine research. Human papillomavirus (2006), World Health Organization, Geneva, Switzerland. http://www.who.int/vaccine_research/diseases/viral_cancers/en/index3.htm l accessed 6/29/06.
3. Bosch F., Manos M., Munoz N., Sherman M., Jansen A., Peto J., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87 (1995) 796-802
4. Walboomers J., Jacobs M., Manos M., Bosch F., Kummer J., Shah K., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
5. Basta A., Adamek K., and Pitynski K. Intraepithelial neoplasia and early stage vulvar cancer. Epidemiological, clinical and virological observations. Eur J Gynaecol Oncol 20 (1999) 111-114
6. Daling J., Madeleine M., Johnson L., Schwartz S., Shera K., Wurscher M., et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 116 (2005) 606-616
7. Daling J., Madeleine M., Schwartz S., Shera K., Carter J., McKnight B., et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84 (2002) 263-270
8. Moscicki A., Hills N., Shiboski S., Powell K., Jay N., Hanson E., et al. Risks for incident human papillomavirus infection and lowgrade squamous intraepithelial lesion development in young females. JAMA 285 (2001) 2995-3002
9. World Health Organization, Department of Vaccines and Other Biologicals and International Agency for Research on Cancer. The current status of development of prophylactic vaccines against human papillomavirus infection: report of a technical meeting, 16-18 February, 1999, Geneva, Switzerland. 1999. Geneva, Switzerland, World Health Organization.
10. Hatch K., and Berek J. Intraepithelial diseases of the cervix, vagina, and vulva. In: Berek J. (Ed). Novak's Gynecology (2002), Lippincott Williams & Wilkins, Philadelphia 471-505
11. Minucci D., Cinel A., Insacco E., and Oselladore M. Epidemiological aspects of vaginal intraepithelial neoplasia (VAIN). Clin Exp Obstet Gynecol 22 (1995) 36-42
12. Maw R., Reitano M., and Roy M. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 9 (1998) 571-578
13. Abramson A., Nouri M., Mullooly V., Fisch G., and Steinberg B. Latent Human Papillomavirus infection is comparable in the larynx and trachea. J Med Virol 72 (2004) 473-477
14. Derkay C., and Darrow D. Recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 115 (2006) 1-11
15. Moscicki A. Impact of HPV infectioninadolescentpopulations. J Adolesc Health 37 (2005) S3-S9
16. Centers for Disease Control and Prevention. National Center for HIV, STD and TB Prevention Division of Sexually Transmitted Diseases. STD prevention: Genital HPV infection [fact sheet]. 2006. Centers for Disease Control and Prevention. http://www.cdc.gov/std/hpv/stdfact-hpv.htmhttp://www.cdc.gov/std/hpv/std fact-hpv.htm accessed 6/29/06.
17. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288 (1996) F55-F78
18. de Villiers E., Fauquet C., Broker T., Bernard H., and zur Hausen H. Classification of papillomaviruses. Virology 324 (2004) 17-27
19. Berzofsky J., Ahlers J., Janik J., Morris J., Oh S., Terabe M., et al. Progress on new vaccine strategies against chronic viral infections. J Clin Invest 114 (2004) 450-462
20. Parkin D., and Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 24 Suppl 3 (2006) S11-S25
21. Munoz N., Bosch F., de Sanjose S., Herrero R., Castellsague X., Shah K., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
22. Clifford G., Gallus S., Herrero R., Munoz N., Snijders P., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
23. Munoz N., Bosch F., Castellsague X., Diaz M., de Sanjose S., Hammouda D., et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111 (2004) 278-285
24. Clifford G., Rana R., Franceschi S., Smith J., Gough G., and Pimenta J. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 1157-1164
25. Clifford G., Smith J., Aguado T., and Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89 (2003) 101-105
26. Bauer H., Ting Y., Greer C., Chambers J., Tashiro C., Chimera J., et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265 (1991) 472-477
27. Ho G., Bierman R., Beardsley L., Chang C., and Burk R. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338 (1998) 423-428
28. Stone K., Karem K., Sternberg M., McQuillan G., Poon A., Unger E., et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 186 (2002) 1396-1402
29. Collins S., Mazloomzadeh S., Winter H., Blomfield P., Bailey A., Young L., et al. High incidence of cervical human papillomavirus infection in women during their first sexual relationship. BJOG 109 (2002) 96-98
30. Bosch F., and de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr (2003) 3-13
31. Auvinen E., Niemi M., Malm C., Zilliacus R., Trontti A., Fingerroos R., et al. High prevalence of HPV among female students in Finland. Scand J Infect Dis 37 (2005) 873-876
32. Winer R., Lee S., Hughes J., Adam D., Kiviat N., and Koutsky L. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157 (2003) 218-226
33. Munoz N., Mendez F., Posso H., Molano M., van den Brule A., Ronderos M., et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 190 (2004) 2077-2087
34. Richardson H., Kelsall G., Tellier P., Voyer H., Abrahamowicz M., Ferenczy A., et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 12 (2003) 485-490
35. Brown D., Shew M., Qadari B., Neptune N., Vargas M., Tu W., et al. A longitudinal study of genital papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 191 (2006) 182-192
36. World Health Organization. Comprehensive cervical cancer control: a guide to essential practice. http://www.who.int/reproductive-health/publications/cervical_cancer_gep/ index.htm accessed 6/24/06. 2006. Geneva, Switzerland, World Health Organization.
37. Ferlay J., Bray F., Pisani P., and Parkin D.M. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, version 2.0. 2004. IARC CancerBase No. 5 (2004), IARC Press, Lyon, France
38. American Cancer Society. Cancer Facts & Figures (2005), American Cancer Society, Atlanta, Ga 1-60
39. American Cancer Society. Cancer Reference Information (2006). Available at: http://www.cancer.org Accessed March 30, 2006.
40. Herrero R., Castellsague X., Pawlita M., Lissowska J., Kee F., Balaram P., et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95 (2003) 1772-1783
41. Joura E. Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia. Curr Opin Obstet Gynecol 14 (2002) 39-43
42. Sturgeon S., Brinton L., Devesa S., and Kurman R. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet. Gynecol. 166 (1992) 1482-1485
43. Buscema J., Naghashfar Z., Sawada E., Daniel R., Woodruff J., and Shah K. The predominance of human papillomavirus type 16 in vulvar neoplasia. Obstet Gynecol 71 (1988) 601-606
44. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 102 (1997) 3-8
45. Burd E. Human papillomavirus and cervical cancer. Clin Microbiol Rev 16 (2003) 1-17
46. Lacey C., Lowndes C., and Shah K. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 24 Suppl 3 (2006) S35-S41
47. Winer R., Kiviat N., Hughes J., Adam D., Lee S., Kuypers J., et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 191 (2005) 731-738
48. Wiley D., Douglas J., Beutner K., Cox T., Fife K., Moscicki A., et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 35 (2002) S210-S224
49. Soper D. Genitourinary infections and sexually transmitted diseases. In: Berek J. (Ed). Novak's Gynecology (2002), Lippincott Williams & Wilkins, Philadelphia 453-470
50. Persson G., Dahlof L., and Krantz I. Physical and psychological effects of anogenital warts on female patients. Sex Transm Dis 20 (1993) 10-13
51. Chandler M. Genital warts: a study of patient anxiety and information needs. Br J Nurs 5 (1996) 174-179
52. Taylor C., Keller M., and Egan J. Advice from affected persons about living with human papillomavirus infection. Image J Nurs Sch 29 (1997) 27-32
53. von Krogh G. Management of anogenital warts (condylomata acuminata). Eur J Dermatol 11 (2001) 598-603
54. Bray F., Loos A., McCarron P., Weiderpass E., Arbyn M., Moller H., et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 14 (2005) 677-686
55. Trottier H., and Franco E. The epidemiology of genital human papillomavirus infection. Vaccine 24 Suppl 1 (2006) S1-S15
56. Planning and implementing cervical cancer prevention and control programs. A manual for managers. 1-279. 2004. Seattle, Washington, Alliance for Cervical Cancer Prevention.
57. Soper D. Reducing the health burden of HPV through vaccination. Infect Dis Obstet Gynecol (2006) 1-5 Article ID 83084
58. Kalliala I., Anttila A., Pukkala E., and Nieminen P. Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ 331 (2005) 1183-1185
59. Kyrgiou M., Koliopoulos G., Martin-Hirsch P., Arbyn M., Prendiville W., and Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 367 (2006) 489-498
60. Frazer I. Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol 4 (2004) 46-54
61. Anttila A., Ronco G., Clifford G., Bray F., Hakama M., Arbyn M., et al. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 91 (2004) 935-941
62. van Ballegooijen M., van den Akker-van Marle, Patnick J., Lynge E., Arbyn M., Anttila A., et al. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 36 (2000) 2177-2188
63. US Department of Health and Human Services. Healthy People 2010. 2nd edition Vol 1-2 (2000), US Government Printing Office, Washington DC (Level III) 2000.
64. Clinical Management Guidelines for Obstetrician-Gynecologists. ACOG Practice Bulletin 102 (2003) 417-427
65. Clinical US Cancer Statistics Working Group. United States Cancer Statistics: 2002 Incidence and Mortality. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute 2002.